AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 102 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $621,000 | -87.2% | 16,400 | -87.2% | 0.41% | -75.2% |
| Q3 2016 | $4,846,000 | +1242.4% | 128,400 | +526.3% | 1.65% | +1047.2% |
| Q2 2016 | $361,000 | +45.0% | 20,500 | 0.0% | 0.14% | +39.8% |
| Q1 2016 | $249,000 | -50.1% | 20,500 | 0.0% | 0.10% | -26.4% |
| Q4 2015 | $499,000 | +37.1% | 20,500 | 0.0% | 0.14% | +100.0% |
| Q3 2015 | $364,000 | -91.5% | 20,500 | -91.6% | 0.07% | -82.8% |
| Q2 2015 | $4,307,000 | -45.8% | 244,000 | -3.8% | 0.41% | -45.9% |
| Q1 2015 | $7,951,000 | +3.8% | 253,700 | -3.3% | 0.75% | +2.3% |
| Q4 2014 | $7,659,000 | +38.8% | 262,400 | -1.6% | 0.73% | +28.8% |
| Q3 2014 | $5,520,000 | -26.0% | 266,800 | -11.4% | 0.57% | -11.1% |
| Q2 2014 | $7,461,000 | +17.7% | 301,200 | +0.7% | 0.64% | +23.7% |
| Q1 2014 | $6,338,000 | +13.6% | 299,100 | -3.7% | 0.52% | +13.3% |
| Q4 2013 | $5,577,000 | – | 310,500 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |